Ani Pharmaceuticals (ANIP) FCF Payout Ratio (2021 - 2025)

Ani Pharmaceuticals (ANIP) has 5 years of FCF Payout Ratio data on file, last reported at 0.01 in Q3 2025.

• For the quarter ending Q3 2025, FCF Payout Ratio fell 99.44% year-over-year to 0.01; the trailing twelve-month figure through Mar 2026 stood at 0.0 (down 81.65% YoY), and the FY2025 full-year result was 0.01, down 75.46% from the prior year.
• FCF Payout Ratio improved to 0.01 in Q3 2025, from 0.01 in the prior quarter.
• In the past five years, FCF Payout Ratio ranged from a high of 1.62 in Q3 2024 to a low of 0.09 in Q4 2022.
• A 5-year average of 0.11 and a median of 0.01 in 2023 frame the typical range for FCF Payout Ratio.
• Across the five-year window, FCF Payout Ratio plunged 467.28% in 2022 and surged 14608.8% in 2024, its largest moves.
• Tracing ANIP's FCF Payout Ratio over 5 years: stood at 0.02 in 2021, then tumbled by 467.28% to 0.09 in 2022, then soared by 110.38% to 0.01 in 2023, then soared by 53.08% to 0.01 in 2024, then plunged by 34.87% to 0.01 in 2025.
• Business Quant data shows ANIP's FCF Payout Ratio at 0.01 in Q3 2025, 0.01 in Q2 2025, and 0.01 in Q1 2025.